Moreover, CD8 and CD4 depletion inhibits the anti-CTLA-4 effect in CT26 subcutaneous models [47] suggesting a primordial role of T cell modulation in the tumor microenvironment as a mechanism of action behind the anti-cancer efficacy of anti-CTLA-4. Here, CD8A is linked to cancer.